Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.62
0.27 (6.21%)
At close: Aug 15, 2025, 2:59 PM
Monte Rosa Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 23.19M | 84.93M | 60.65M | 9.22M | 4.7M | 1.06M | 8.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.13M | n/a | 2.06M | 2.1M | 2.06M | 1.9M | 1.85M | 1.83M | 1.39M | 1.15M | 2.68M | 2.58M | 2.17M | 1.13M | 809K | 582K | 467K | 274K |
Gross Profit | 21.07M | 84.93M | 56.48M | 9.22M | 2.63M | -833K | -1.85M | -1.83M | -1.39M | -1.15M | -2.68M | -2.58M | -2.17M | -1.13M | -809K | -582K | -467K | -274K |
Operating Income | -15.55M | 44.04M | 13M | -26.53M | -32.64M | -34.95M | -34.86M | -36.97M | -37.22M | -34.26M | -32.49M | -28.36M | -27.23M | -24.3M | -23.39M | -19.87M | -18.12M | -11.5M |
Interest Income | 3.07M | 3.44M | 2.6M | 2.89M | 2.64M | 2.44M | 2.37M | 2.23M | 2.3M | 2.44M | 1.99M | 997K | 628K | 149K | 13K | 13K | 14K | 6K |
Pretax Income | -11.1M | 47.71M | 15.6M | -23.79M | -30.06M | -31.89M | -33.27M | -34.71M | -34.99M | -32.04M | -30.78M | -27.32M | -26.47M | -23.93M | -23.44M | -19.84M | -18.41M | -12.28M |
Net Income | -12.29M | 46.88M | 13.44M | -23.86M | -30.31M | -31.97M | -33.25M | -34.88M | -35.18M | -29.82M | -29.07M | -26.27M | -25.71M | -23.56M | -23.44M | -19.84M | -18.41M | -12.28M |
Selling & General & Admin | 8.1M | 8.7M | 8.78M | 8.13M | 9.28M | 8.98M | 7.73M | 8.66M | 8.14M | 7.5M | 7.62M | 7.02M | 6.29M | 6.39M | 5.26M | 4.75M | 3.49M | 2.23M |
Research & Development | 30.65M | 32.19M | 36.8M | 27.62M | 26M | 25.13M | 25.29M | 28.31M | 29.08M | 26.75M | 24.87M | 21.34M | 20.94M | 17.91M | 18.13M | 15.12M | 14.64M | 9.27M |
Other Expenses | n/a | n/a | -2.1M | n/a | n/a | n/a | n/a | -1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -960K |
Operating Expenses | 38.75M | 40.89M | 43.48M | 35.74M | 35.28M | 34.11M | 33.02M | 35.13M | 37.22M | 34.26M | 32.49M | 28.36M | 27.23M | 24.3M | 23.39M | 19.87M | 18.12M | 11.5M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.75M | 40.89M | 47.64M | 35.74M | 37.34M | 36.01M | 34.86M | 36.97M | 37.22M | 34.26M | 32.49M | 28.36M | 27.23M | 24.3M | 23.39M | 19.87M | 18.12M | 11.5M |
Income Tax Expense | 1.2M | 822K | 2.16M | 71K | 252K | 83K | -22K | -170K | 190K | -2.22M | -1.71M | -1.04M | -762K | -370K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 82.19M | 82.15M | 61.44M | 82.01M | 71.23M | 60.16M | 56.93M | 49.81M | 49.43M | 49.35M | 48.89M | 46.73M | 46.67M | 46.6M | 45.99M | 45.99M | 5.07M | 42.54M |
Shares Outstanding (Diluted) | 82.19M | 82.96M | 61.44M | 82.01M | 71.23M | 60.16M | 56.93M | 49.81M | 49.43M | 49.35M | 48.89M | 46.73M | 46.67M | 46.6M | 45.99M | 45.99M | 5.07M | 42.54M |
EPS (Basic) | -0.15 | 0.57 | 0.22 | -0.29 | -0.43 | -0.53 | -0.58 | -0.7 | -0.71 | -0.6 | -0.59 | -0.56 | -0.55 | -0.51 | -0.51 | -0.43 | -3.63 | -0.29 |
EPS (Diluted) | -0.15 | 0.57 | 0.22 | -0.29 | -0.43 | -0.53 | -0.58 | -0.7 | -0.71 | -0.6 | -0.59 | -0.56 | -0.55 | -0.51 | -0.51 | -0.43 | -3.63 | -0.29 |
EBITDA | -15.55M | 46.08M | 15.06M | -24.42M | -30.58M | -33.05M | -33.02M | -35.13M | -35.83M | -33.11M | -31.42M | -27.33M | -26.34M | -23.55M | -22.58M | -19.29M | -17.66M | -11.23M |
EBIT | -11.1M | 44.04M | 13M | -26.53M | -32.64M | -34.95M | -34.86M | -36.97M | -37.22M | -34.26M | -32.49M | -28.36M | -27.23M | -24.3M | -23.39M | -19.87M | -18.12M | -11.5M |
Depreciation & Amortization | 2.13M | 2.05M | 2.06M | 2.1M | 2.06M | 1.9M | 1.85M | 1.83M | 1.39M | 1.15M | 2.68M | 2.58M | 2.17M | 1.13M | 809K | 582K | 467K | 274K |